ZA97848B - New 2,3-Benzodiazepine derivatives, their production and use as pharmaceutical agents. - Google Patents

New 2,3-Benzodiazepine derivatives, their production and use as pharmaceutical agents.

Info

Publication number
ZA97848B
ZA97848B ZA9700848A ZA97848A ZA97848B ZA 97848 B ZA97848 B ZA 97848B ZA 9700848 A ZA9700848 A ZA 9700848A ZA 97848 A ZA97848 A ZA 97848A ZA 97848 B ZA97848 B ZA 97848B
Authority
ZA
South Africa
Prior art keywords
new
production
pharmaceutical agents
benzodiazepine derivatives
hydrogen
Prior art date
Application number
ZA9700848A
Other languages
English (en)
Inventor
Emese Csuzdi
Tamas Hamori
Gizella Abraham
Sandor Solyom
Istvan Tarnawa
Pal Berzsenyi
Ferenc Andrasi
Istvan Ling
Antal Simay
Melinda Gal
Katalin Horvath
Eszter Szentkuti Hodulane
Marta Szoellosy
Istvan Pallagi
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7785064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA97848(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA97848B publication Critical patent/ZA97848B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9700848A 1996-02-01 1997-01-31 New 2,3-Benzodiazepine derivatives, their production and use as pharmaceutical agents. ZA97848B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19604919A DE19604919A1 (de) 1996-02-01 1996-02-01 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ZA97848B true ZA97848B (en) 1997-08-04

Family

ID=7785064

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9700848A ZA97848B (en) 1996-02-01 1997-01-31 New 2,3-Benzodiazepine derivatives, their production and use as pharmaceutical agents.

Country Status (31)

Country Link
US (2) US6323197B1 (cs)
EP (1) EP0888356B1 (cs)
JP (1) JP4141499B2 (cs)
KR (1) KR100465269B1 (cs)
CN (1) CN1096464C (cs)
AT (1) ATE214703T1 (cs)
AU (1) AU724956B2 (cs)
BG (1) BG63394B1 (cs)
BR (1) BR9707335A (cs)
CA (1) CA2245539C (cs)
CZ (1) CZ289658B6 (cs)
DE (2) DE19604919A1 (cs)
DK (1) DK0888356T3 (cs)
EE (1) EE04017B1 (cs)
ES (1) ES2173435T3 (cs)
HK (1) HK1018782A1 (cs)
HU (1) HU224636B1 (cs)
IL (1) IL125480A (cs)
IS (1) IS2103B (cs)
MY (1) MY119140A (cs)
NO (1) NO983510L (cs)
NZ (1) NZ331187A (cs)
PL (1) PL187128B1 (cs)
PT (1) PT888356E (cs)
RU (1) RU2179557C2 (cs)
SK (1) SK283563B6 (cs)
TR (1) TR199801485T2 (cs)
TW (1) TW438801B (cs)
UA (1) UA56157C2 (cs)
WO (1) WO1997028163A1 (cs)
ZA (1) ZA97848B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9701325A1 (hu) 1997-07-31 2000-08-28 Gyógyszerkutató Intézet Kft. Új 2,3-benzodiazepin-származékok
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
WO2000001376A2 (en) * 1998-07-02 2000-01-13 Eisai Co., Ltd Pharmaceutical compositions and their uses for treatment of demyelinating disorders
WO2001098280A2 (en) * 2000-06-16 2001-12-27 Annovis, Inc. 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors
DE10041671C1 (de) * 2000-08-10 2002-06-13 Schering Ag Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung
US20070280876A1 (en) * 2004-03-25 2007-12-06 William Marsh Rice University Functionalization of Carbon Nanotubes in Acidic Media
US20060166969A1 (en) * 2005-01-14 2006-07-27 Turski Lechoslaw A AMPA antagonists for the treatment of dizziness, including vertigo and Meniere's disorder
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891871A (en) 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
HU9600871D0 (en) * 1996-04-04 1996-05-28 Gyogyszerkutato Intezet New 2,3-benzodiazepine derivatives

Also Published As

Publication number Publication date
CZ289658B6 (cs) 2002-03-13
JP2000503997A (ja) 2000-04-04
RU2179557C2 (ru) 2002-02-20
TW438801B (en) 2001-06-07
BG63394B1 (bg) 2001-12-29
EP0888356A1 (de) 1999-01-07
HU224636B1 (hu) 2005-12-28
PL187128B1 (pl) 2004-05-31
BG102658A (en) 1999-06-30
DE19604919A1 (de) 1997-08-07
EE9800225A (et) 1998-12-15
DK0888356T3 (da) 2002-06-03
WO1997028163A1 (de) 1997-08-07
DE59706686D1 (de) 2002-04-25
ES2173435T3 (es) 2002-10-16
PT888356E (pt) 2002-09-30
EE04017B1 (et) 2003-04-15
ATE214703T1 (de) 2002-04-15
NO983510L (no) 1998-09-30
US20020052364A1 (en) 2002-05-02
AU724956B2 (en) 2000-10-05
IS2103B (is) 2006-05-15
US6323197B1 (en) 2001-11-27
MY119140A (en) 2005-04-30
KR100465269B1 (ko) 2005-04-14
EP0888356B1 (de) 2002-03-20
CA2245539C (en) 2005-10-04
HK1018782A1 (en) 2000-01-07
IS4794A (is) 1998-07-06
US6600036B2 (en) 2003-07-29
HUP9901417A2 (hu) 1999-08-30
SK103398A3 (en) 1999-01-11
BR9707335A (pt) 1999-07-20
IL125480A (en) 2002-07-25
JP4141499B2 (ja) 2008-08-27
PL328224A1 (en) 1999-01-18
CN1210538A (zh) 1999-03-10
AU2502997A (en) 1997-08-22
NO983510D0 (no) 1998-07-30
IL125480A0 (en) 1999-03-12
HUP9901417A3 (en) 2001-11-28
CZ242798A3 (cs) 1999-01-13
UA56157C2 (uk) 2003-05-15
CA2245539A1 (en) 1997-08-07
CN1096464C (zh) 2002-12-18
KR19990082192A (ko) 1999-11-25
SK283563B6 (sk) 2003-09-11
TR199801485T2 (xx) 1998-10-21
NZ331187A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
BG104561A (en) Aryl fused azapolycyclic compounds
HUP0105414A2 (hu) Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
MY107157A (en) Quinuclidine derivatives.
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
HUT61543A (en) Process for producing serotonin antagonist indole derivatives and pharmaceutical compositions comprising same as active ingredient
MY117896A (en) Quinazoline derivatives
MY105438A (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles.
ATE246190T1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
NZ514487A (en) Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
GEP20104959B (en) Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
SE9702564D0 (sv) New compounds
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
ZA97848B (en) New 2,3-Benzodiazepine derivatives, their production and use as pharmaceutical agents.
SE9702563D0 (sv) Compounds
TW360650B (en) Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them
HUP0003861A2 (hu) Kinolin-4-il-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
ATE56713T1 (de) 1,2,3,4,4a,9b-hexahydro-4aaminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
PT728748E (pt) Novos derivados da benzodiazepina
YU140491A (sh) 6-supstituisani-tetrahidrobenz(c,d) indoli
MY105852A (en) New 2-methoxycarbonyl substituted n, n'' -di- (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.